Contraceptive Pills

Lupin gets US drug regulator's nod for generic oral contraceptive pill

Drug maker Lupin on Friday said it has received approval from the US health regulator to market Drospirenone tablets, used to prevent pregnancy, in the American market. The company has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drospirenone Tablets in 4 mg strength, the Mumbai-based drug maker said in a statement. The company's product is the generic equivalent of Exeltis USA Inc's Slynd tablets, it added. As per IQVIA MAT September 2022 data, Drospirenone tablets had estimated annual sales of USD 141 million in the US market.

Amid abortion ban, US FDA mulls to okay over-the-counter birth control pill

Amid the US Supreme Court's decision to ban abortion in the country, the Food and Drug Administration is considering to approve the first-ever over the counter (OTC) birth control pill

Lupin launches generic contraceptive drug Merzee capsules in US

Slayback had earlier launched this product in the US in February 2021

Better choice of contraceptives can prevent breast cancer, says study

A new study found that contraceptive-related breast cancer can be prevented by more informed choices about the composition of contraceptives

Buying birth control pills online may be safe and efficient, says study

Experts have been concerned about the quality of services provided by online vendors

Contraceptive pills driving fall in ovarian cancer deaths

Decline in hormone replacement therapy to manage menopausal symptoms and better diagnosis and treatment may also play a role